Preferred Label : carbidopa, levodopa drug combination;

Obsolete resource : false;

MeSH note : contains levodopa & carbidopa;

CISMeF synonym : CR-3; CR-5; carbidopa levodopa; BMS brand of carbidopa, levodopa drug combination; Bristol-Myers squibb brand of carbidopa, levodopa drug combination; IPX066; duodopa; grifoparkin; laboratorios chile SA brand of carbidopa, levodopa drug combination; nacom; parcopa; schwarz pharma brand of carbidopa, levodopa drug combination; sinemet CR; tidomed;

MeSH synonym : carbidopa - levodopa;

MeSH hyponym : Nakom; Sinemet CR4;

MeSH Related Number : sinemet; 57308-51-7;

Related CAS MeSH : 57308-51-7 (Sinemet);

Is substance : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/levodopa-carbidopa
2021
false
false
false
France
French
risk management
carbidopa
levodopa
drug combinations
carbidopa, levodopa drug combination
Intestinal Route of Administration
patient care
nursing care
patient care planning
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/actualites/maladie-de-parkinson-remise-a-disposition-et-evolution-de-sinemet-lp-200-mg-50-mg
2021
false
false
false
France
French
drug information
carbidopa, levodopa drug combination
carbidopa
levodopa
drug combinations

---
https://www.has-sante.fr/jcms/p_3118137/fr/duodopa
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
carbidopa, levodopa drug combination
levodopa and decarboxylase inhibitor
parkinson disease
antiparkinson agents
dopamine agonists
enzyme inhibitors
dopa decarboxylase
evaluation of the transparency committee
carbidopa
levodopa
drug combinations

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1248
2019
false
false
false
false
France
parkinson disease
case reports
journal article
levodopa
neutropenia
carbidopa
carbidopa, levodopa drug combination
drug combinations
carbidopa
levodopa
drug combinations

---
https://ansm.sante.fr/actualites/sinemet-levodopa-carbidopa-modification-des-comprimes-100mg-10mg-et-250mg-25mg
2019
false
false
false
France
French
pharmacovigilance note
carbidopa, levodopa drug combination
administration, oral
carbidopa
levodopa
drug combinations

---
https://ansm.sante.fr/actualites/ruptures-de-stock-prolongees-de-sinemet-levodopa-carbidopa-lansm-met-en-place-un-plan-dactions-afin-deviter-toute-interruption-de-traitement-chez-les-patients-concernes
2018
false
false
false
false
France
French
drug information
patients guideline
carbidopa, levodopa drug combination
administration, oral
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
parkinsonian disorders
carbidopa
levodopa
drug combinations

---
https://www.ansm.sante.fr/actualites/ruptures-de-stock-prolongees-de-sinemet-levodopa-carbidopa-lansm-met-en-place-un-plan-dactions-afin-deviter-toute-interruption-de-traitement-chez-les-patients-concernes
2018
false
false
false
France
French
drug information
guideline
carbidopa, levodopa drug combination
administration, oral
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
parkinsonian disorders
carbidopa
levodopa
drug combinations

---
https://ansm.sante.fr/informations-de-securite/sinemet-recommandations-aux-professionnels-de-sante-dans-le-contexte-des-ruptures-de-stocks
2018
false
false
false
France
French
carbidopa, levodopa drug combination
carbidopa, levodopa drug combination
guidelines for drug use
antiparkinson agents
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
drugs, generic
carbidopa
levodopa
drug combinations
carbidopa
levodopa
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2598644/fr/carbidopa-levodopa-teva
http://www.has-sante.fr/portail/jcms/c_1098674/carbidopa-levodopa-teva
2016
false
France
French
carbidopa
carbidopa, levodopa drug combination
levodopa
administration, oral
drug combinations
levodopa and decarboxylase inhibitor
dopa decarboxylase
antiparkinson agents
dopamine agents
insurance, health, reimbursement
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Numient
2015
false
United Kingdom
English
French
drug approval
europe
summary of product characteristics
package leaflet
drug evaluation
syndication feed
carbidopa
levodopa
adult
carbidopa, levodopa drug combination
Aromatic Amino Acid Decarboxylase Inhibitors
Aromatic Amino Acid Decarboxylase Inhibitors
treatment outcome
carbidopa
carbidopa, levodopa drug combination
levodopa
administration, oral
drug combinations
levodopa and decarboxylase inhibitor
dopa decarboxylase
antiparkinson agents
dopamine agents
insurance, health, reimbursement
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2040120/fr/sinemet
http://www.has-sante.fr/portail/jcms/c_958810/sinemet
2015
false
France
French
carbidopa, levodopa drug combination
levodopa and decarboxylase inhibitor
carbidopa
levodopa
drug combinations
administration, oral
Delayed-Action preparations
insurance, health, reimbursement
antiparkinson agents
parkinson disease
parkinsonian disorders
dopamine agonists
dopa decarboxylase
enzyme inhibitors
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1635266/fr/duodopa
http://www.has-sante.fr/portail/jcms/c_1635476/fr/duodopa-24072013-avis-ct12680
http://www.has-sante.fr/portail/display.jsp?id=c_604934
http://www.has-sante.fr/portail/display.jsp?id=c_401022
2013
France
French
evaluation of the transparency committee
carbidopa, levodopa drug combination
drug combinations
levodopa
carbidopa
antiparkinson agents
dopamine agonists
levodopa and decarboxylase inhibitor
parkinson disease
catheters, indwelling
parkinson disease
infusions, parenteral

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64275824
2012
France
summary of product characteristics
package leaflet
carbidopa
levodopa
carbidopa, levodopa drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60914000
2012
France
summary of product characteristics
package leaflet
tablets
carbidopa, levodopa drug combination
levodopa
carbidopa

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64793585
2012
France
summary of product characteristics
package leaflet
levodopa
carbidopa
carbidopa, levodopa drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61721132
2012
France
summary of product characteristics
package leaflet
tablets
levodopa
carbidopa, levodopa drug combination
carbidopa

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60092590
2010
France
French
administration, oral
carbidopa, levodopa drug combination
carbidopa, levodopa drug combination
drug combinations
levodopa
levodopa
carbidopa
carbidopa
antiparkinson agents
antiparkinson agents
dopamine agonists
dopamine agonists
levodopa and decarboxylase inhibitor
parkinsonian disorders
parkinson disease
adult
aged
drug interactions
pregnancy
dopa decarboxylase
tablets
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64757532
2010
France
French
drug combinations
carbidopa, levodopa drug combination
carbidopa, levodopa drug combination
dopa decarboxylase
antiparkinson agents
antiparkinson agents
dopamine agonists
dopamine agonists
parkinson disease
drug interactions
levodopa and decarboxylase inhibitor
levodopa
levodopa
carbidopa
carbidopa
summary of product characteristics
package leaflet

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Duodopa_July_24_2009_f.pdf
2009
Canada
French
carbidopa, levodopa drug combination
drug combinations
carbidopa
levodopa
antiparkinson agents
gels
randomized controlled trials as topic
treatment outcome
infusions, parenteral
Cost-Benefit analysis
levodopa and decarboxylase inhibitor
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_538026
2007
France
evaluation of the transparency committee
levodopa
carbidopa
carbidopa, levodopa drug combination
tablets

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.